IVD Quality Control Market by Offering (Product [Serum, Blood, Urine-based], Data Management, Service), Technology (Biochemistry, Molecular, Immunoassay, Hematology), Application (Infectious Diseases, Oncology, Cardiology), and End User – Global Forecast

IVD Quality Control Market by Offering (Product [Serum, Blood, Urine-based], Data Management, Service), Technology (Biochemistry, Molecular, Immunoassay, Hematology), Application (Infectious Diseases, Oncology, Cardiology), and End User–Global Forecast to 2030


The IVD quality control market is expected to reach $2.19 billion by 2030, at a CAGR of 4.3% from 2023 to 2030.

After extensive primary and secondary research, the report provides an in-depth analysis of the IVD quality control market. The report also provides insights into the key drivers, restraints, challenges, and opportunities in the IVD quality control market. The growth of the IVD quality control market is driven by the rising prevalence of chronic diseases, coupled with the increasing geriatric population, growing demand for third-party quality controls, need for internal and external quality assessment reports, increasing number of clinical laboratories, growing demand for Point-of-Care (POC) and rapid diagnostics. However, stringent technical requirements and regulatory processes for quality controls restrain this market's growth.

The growing demand for multi-analyte and multi-instrument controls offers opportunities for market growth. However, the evolving regulatory landscape and lack of access to quality control/quality assurance materials are the major challenges to market growth.

Among the offering, in 2023, the quality control products segment is estimated to account for the largest share of the IVD quality control market. Increasing adoption of diagnostic products, demand for external quality assessment programs as these programs use quality controls in their programs, development of multi-analyte quality controls, new product launches, and increasing demand for independent controls contribute to the segments’ largest share.

Among the technologies, in 2023, the immunoassay/immunochemistry segment is estimated to account for the largest share of the IVD quality control market. The growing prevalence of chronic and infectious diseases and the increased adoption of immunoassay/immunochemistry tests, technological innovations in these tests, and the simultaneous development of quality control contributed to the segment's largest share.

Among the application, in 2023, the infectious diseases segment is estimated to account for the largest share of the IVD quality control market. The increasing prevalence of infectious diseases has led to the availability of a broad range of quality controls that are designed to monitor the assay precision of IVD tests for infectious diseases such as hepatitis, retrovirus, sexually transmitted diseases, congenital diseases, and other infectious diseases. According to the WHO, in 2020, there were an estimated 376 million new cases of sexually transmitted infections (STIs) worldwide, with chlamydia accounting for 129 million, gonorrhea for 82 million, syphilis for 7.1 million, and trichomoniasis for 156 million of the reported cases. The need for diagnosis of such infectious diseases also required quality controls for the quality assessment of tests, which further supported the largest share of the segment.

Among the end users, in 2023, the hospitals & clinics segment is estimated to account for the largest share of the IVD quality control market. The large segment share is majorly attributed to the large volume of diagnostics tests carried out in the hospitals, the rising prevalence of healthcare-associated infections (HAIs), increasing healthcare expenditure, and the rising number of hospitals and clinics across emerging markets.

An in-depth analysis of the geographical scenario of the IVD quality control market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is estimated to account for the largest share of the IVD quality control market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The high prevalence of chronic and infectious diseases, increasing awareness regarding early disease diagnosis, growing adoption of advanced diagnostic products, and increasing funding activities, coupled with novel developments in diagnostic technologies, are the factors supporting the largest share of this market.

The key players operating in the IVD quality control market are Seimens Healthineers AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), LGC Group (U.K.), Thermo Fisher Scientific Inc. (U.S.), SERO AS (Norway), Randox Laboratories Ltd. (U.K.), QuidelOrtho Corporation (U.S.), Streck LLC (U.S.), Microbiologics, Inc. (U.S.), and Bio-Techne Corporation (U.S.)

Scope of the Report:

IVD Quality Control Market Assessment - by Offering

Quality Control Products
Quality Control Products, by Type
Serum/Plasma-based Controls
Whole Blood-based Controls
Urine-based Controls
Other Controls
Quality Control Products, by Function
Independent Controls
Instrument-Specific Controls
Quality Assessment Services
Data Management Solutions

Notes: Other controls include saliva-based controls, cerebrospinal fluid-based, and protein controls.

IVD Quality Control Market Assessment - by Technology

Immunoassay/Immunochemistry
Biochemistry/Clinical Chemistry
Molecular Diagnostics
Hematology
Coagulation/Hemostasis
Microbiology
Other Technologies

Notes:Other technologies include histochemistry, urinalysis, and whole-blood glucose monitoring

IVD Quality Control Market Assessment - by Application

Infectious Diseases
Oncology
Cardiology
Autoimmune Disorders
Neurology
Other Applications

Notes:Other applications include pregnancy and fertility testing, drug abuse testing, diabetes, genetic disorders, and trace elements testing

IVD Quality Control Market Assessment - by End User

Hospitals & Clinics
Diagnostic Laboratories
Academic Institutes & Research Laboratories
Other End Users

Notes:Other end users include home care, nursing homes, ambulatory care centers, and transfusion laboratories.

IVD Quality Control Market Assessment - by Geography

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa

IVD Quality Control Market - Global Opportunity Analysis and Industry Forecast (2023–2030) - Report Summary
Report MetricsDetails
Years Considered2021 - 2030
Base Year2022
Forecast Period2023-2030
Page Count267
Units ReferencedValue (USD Million)
Segments/Key TopicsMarket by Offering, Technology, Application, and End User
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Key Companies MentionedSiemens Healthineers AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), LGC Group (U.K.), Thermo Fisher Scientific Inc. (U.S.), SERO AS (Norway), Randox Laboratories Ltd. (U.K.), QuidelOrtho Corporation (U.S.), Streck LLC (U.S.), Microbiologics, Inc. (U.S.), and Bio-Techne Corporation (U.S.)


FAQs About the Report

What is the focus of the IVD quality control market study?


This study covers quality control products, quality assessment services, and data management solutions applied in hospitals & clinics, diagnostic laboratories, academic institutes & research laboratories, and other end users.

What is the revenue generated from the sales of IVD quality control products & services? At what rate is their demand expected to grow for the next 5-7 years?

The IVD quality control market is projected to reach $2.19 billion by 2030, at a CAGR of 4.3% during the forecast period.

Which offering is expected to hold the major share of the market in 2023?

Based on offering, in 2023, the quality control products segment is expected to account for the largest share of the IVD quality control market. Development of multi-analyte quality controls and new product launches contribute to the segment’s largest share.

Which technology segment is expected to hold the major share of the market in 2023?

Based on technology, in 2023, the immunoassay/immunochemistry segment is expected to account for the largest share of the IVD quality control market. The growing number of immunoassay/immunochemistry tests, as they provide rapid, convenient, and accurate results for the detection and quantitation of targets and continuous development of new biomarkers, contribute to the segment’s largest share.

Which application segment is expected to hold the major share of the market in 2023?

Based on application, in 2023, the infectious diseases segment is expected to account for the largest share of the IVD quality control market. The rising prevalence of infectious diseases and government initiatives to promote awareness and testing of these infectious diseases contribute to the segment’s largest share.

Which end user segment is expected to hold the major share of the market in 2023?

Based on end user, in 2023, the hospitals & clinics segment is expected to account for the largest share of the IVD quality control market. The expansion of hospitals, the increasing number of patients visiting the hospitals & clinics, and the collaborations between hospitals and government organizations for screening programs support the segment’s largest share.

What are the key factors supporting the growth of this market? Also, what are the major opportunities for existing market players and new entrants in the IVD quality control market?

The rising prevalence of chronic diseases, coupled with the increasing geriatric population, growing demand for third-party quality controls, need for internal and external quality assessment reports, increasing number of clinical laboratories, growing demand for Point-of-Care (POC) and rapid diagnostics are some of the factors driving the growth of this market. Additionally, the growing demand for multi-analyte and multi-instrument controls offers opportunities for market growth.

Who are the major players operating in the IVD quality control market?

Key companies operating in the IVD quality control market are Seimens Healthineers AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), LGC Group (U.K.), Thermo Fisher Scientific Inc. (U.S.), SERO AS (Norway), Randox Laboratories Ltd. (U.K.), QuidelOrtho Corporation (U.S.), Streck LLC (U.S.), Microbiologics, Inc. (U.S.), and Bio-Techne Corporation (U.S.)


1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.2. Factor Analysis
4.3. Technology Trends
4.4. Regulatory Analysis
4.4.1. Regulations for IVD Products
4.4.1.1. North America
4.4.1.1.1. U.S.
4.4.1.1.2. Canada
4.4.1.2. Europe
4.4.1.3. Asia-Pacific
4.4.1.3.1. China
4.4.1.3.2. Japan
4.4.1.3.3. India
4.4.1.4. Latin America
4.4.1.5. Middle East & Africa
4.4.2. Regulations for Quality Management
4.4.2.1. North America
4.4.2.1.1. U.S.
4.4.2.1.2. Canada
4.4.2.2. Europe
4.4.2.2.1. Germany
4.4.2.2.2. France
4.4.2.2.3. U.K.
4.4.2.2.4. Italy
4.4.2.2.5. Spain
4.4.2.2.6. Rest of Europe (RoE)
4.4.2.3. Asia-Pacific
4.4.2.3.1. China
4.4.2.3.2. Japan
4.4.2.3.3. India
4.4.2.3.4. Rest of Asia-Pacific (RoAPAC)
4.4.2.4. Latin America
4.4.2.5. Middle East & Africa
4.5. Pricing Analysis
4.6. Porter’s Five Forces Analysis
4.6.1. Bargaining Power of Buyers
4.6.2. Bargaining Power of Suppliers
4.6.3. Threat of Substitutes
4.6.4. Threat of New Entrants
4.6.5. Degree of Competition
4.7. Associated Market Analysis: In Vitro Diagnostics (IVD) Market
5. IVD Quality Control Market Assessment—by Offering
5.1. Overview
5.2. Quality Control Products
5.2.1. Quality Control Products, by Type
5.2.1.1. Serum/Plasma-based Controls
5.2.1.2. Whole Blood-based Controls
5.2.1.3. Urine-based Controls
5.2.1.4. Other Controls
5.2.2. Quality Control Products, by Function
5.2.2.1. Independent Controls
5.2.2.2. Instrument-specific Controls
5.3. Quality Assessment Services
5.4. Data Management Solutions
6. IVD Quality Control Market Assessment—by Technology
6.1. Overview
6.2. Immunoassay/Immunochemistry
6.3. Biochemistry/Clinical Chemistry
6.4. Molecular Diagnostics
6.5. Hematology
6.6. Coagulation/Hemostasis
6.7. Microbiology
6.8. Other Technologies
7. Global IVD Quality Control Market Assessment—by Application
7.1. Overview
7.2. Infectious Diseases
7.3. Oncology
7.4. Cardiology
7.5. Autoimmune Disorders
7.6. Neurology
7.7. Other Applications
8. IVD Quality Control Market Assessment—by End User
8.1. Overview
8.2. Hospitals & Clinics
8.3. Diagnostic Laboratories
8.4. Academic Institutes & Research Laboratories
8.5. Other End Users
9. IVD Quality Control Market Assessment—by Geography
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Rest of Asia-Pacific
9.5. Latin America
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
9.6. Middle East & Africa
10. Competition Analysis
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
10.4.1. Industry Leaders
10.4.2. Market Differentiators
10.4.3. Vanguards
10.4.4. Emerging Companies
11. Company Profiles
11.1. Siemens Healthineers AG
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Product Portfolio
11.1.4. SWOT Analysis
11.2. Bio-Rad Laboratories, Inc.
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Product Portfolio
11.2.4. Strategic Developments
11.2.5. SWOT Analysis
11.3. Danaher Corporation
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Product Portfolio
11.3.4. SWOT Analysis
11.4. LGC Group
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Product Portfolio
11.4.4. Strategic Developments
11.4.5. SWOT Analysis
11.5. Thermo Fisher Scientific Inc.
11.5.1. Business Overview
11.5.2. Financial Overview
11.5.3. Product Portfolio
11.5.4. Strategic Developments
11.5.5. SWOT Analysis
11.6. Randox Laboratories Ltd.
11.6.1. Company Overview
11.6.2. Product Portfolio
11.6.3. Strategic Developments
11.6.4. SWOT Analysis
11.7. SERO AS
11.7.1. Company Overview
11.7.2. Product Portfolio
11.7.3. Strategic Developments
11.8. QuidelOrtho Corporation
11.8.1. Business Overview
11.8.2. Financial Overview
11.8.3. Product Portfolio
11.8.4. Strategic Developments
11.9. Streck LLC
11.9.1. Company Overview
11.9.2. Product Portfolio
11.9.3. Strategic Developments
11.10. Microbiologics, Inc.
11.10.1. Company Overview
11.10.2. Product Portfolio
11.10.3. Strategic Developments
11.11. Bio-Techne Corporation
11.11.1. Company Overview
11.11.2. Financial Overview
11.11.3. Product Portfolio
11.11.4. Strategic Developments
12. Appendix
12.1. Available Customization
12.2. Related Reports
List of Tables
Table 1 A Comparison Between the Characteristics of PBRTQC and Statistical IQC
Table 2 Regulatory Authorities Governing IVD Quality Controls, by Country/Region
Table 3 IVD Quality Control Product Pricing
Table 4 Global IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 5 Global Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 6 Global Quality Control Products Market, by Country/Region, 2021–2030 (USD Million)
Table 7 Global Serum/Plasma-Based Controls Market, by Country/Region, 2021–2030 (USD Million)
Table 8 Global Whole Blood-Based Controls Market, by Country/Region, 2021–2030 (USD Million)
Table 9 Global Urine-Based Controls Market, by Country/Region, 2021–2030 (USD Million)
Table 10 Global Other Controls Market, by Country/Region, 2021–2030 (USD Million)
Table 11 Global Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 12 Global Independent Controls Market, by Country/Region, 2021–2030 (USD Million)
Table 13 Global Instrument-Specific Controls Market, by Country/Region, 2021–2030 (USD Million)
Table 14 Global Quality Assessment Services Market, by Country/Region, 2021–2030 (USD Million)
Table 15 Global Data Management Solutions Market, by Country/Region, 2021–2030 (USD Million)
Table 16 Global IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 17 Global IVD Quality Control Market for Immunoassay/Immunochemistry, by Country/Region, 2021–2030 (USD Million)
Table 18 Global IVD Quality Control Market for Biochemistry/Clinical Chemistry, by Country/Region, 2021–2030 (USD Million)
Table 19 Global IVD Quality Control Market for Molecular Diagnostics, by Country/Region, 2021–2030 (USD Million)
Table 20 Global IVD Quality Control Market for Hematology, by Country/Region, 2021–2030 (USD Million)
Table 21 Global IVD Quality Control Market for Coagulation/Hemostasis, by Country/Region, 2021–2030 (USD Million)
Table 22 Global IVD Quality Control Market for Microbiology, by Country/Region, 2021–2030 (USD Million)
Table 23 Global IVD Quality Control Market for Other Technologies, by Country/Region, 2021–2030 (USD Million)
Table 24 Global IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 25 Global IVD Quality Control Market for Infectious Diseases, by Country/Region, 2021–2030 (USD Million)
Table 26 Increase in the Number of New Cancer Cases Globally (2020-2040)
Table 27 Global IVD Quality Control Market for Oncology, by Country/Region, 2021–2030 (USD Million)
Table 28 Global IVD Quality Control Market for Cardiology, by Country/Region, 2021–2030 (USD Million)
Table 29 Global IVD Quality Control Market for Autoimmune Disorders, by Country/Region, 2021–2030 (USD Million)
Table 30 Global IVD Quality Control Market for Neurology, by Country/Region, 2021–2030 (USD Million)
Table 31 Global IVD Quality Control Market for Other Applications, by Country/Region, 2021–2030 (USD Million)
Table 32 Global IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 33 Global IVD Quality Control Market for Hospitals & Clinics, by Country/Region, 2021–2030 (USD Million)
Table 34 Global IVD Quality Control Market for Diagnostic Laboratories, by Country/Region, 2021–2030 (USD Million)
Table 35 Global IVD Quality Control Market for Academic Institutes & Research Laboratories, by Country/Region, 2021–2030 (USD Million)
Table 36 Global IVD Quality Control Market for Other End Users, by Country/Region, 2021–2030 (USD Million)
Table 37 Global IVD Quality Control Market, by Country/Region, 2021–2030 (USD Million)
Table 38 North America: Estimated Cancer Cases, 2020–2030
Table 39 North America: IVD Quality Control Market, by Country, 2021–2030 (USD Million)
Table 40 North America: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 41 North America: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 42 North America: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 43 North America: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 44 North America: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 45 North America: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 46 U.S.: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 47 U.S.: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 48 U.S.: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 49 U.S.: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 50 U.S.: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 51 U.S.: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 52 Canada: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 53 Canada: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 54 Canada: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 55 Canada: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 56 Canada: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 57 Canada: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 58 Europe: IVD Quality Control Market, by Country/Region, 2021–2030 (USD Million)
Table 59 Europe: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 60 Europe: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 61 Europe: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 62 Europe: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 63 Europe: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 64 Europe: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 65 Germany: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 66 Germany: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 67 Germany: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 68 Germany: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 69 Germany: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 70 Germany: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 71 France: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 72 France: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 73 France: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 74 France: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 75 France: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 76 France: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 77 U.K.: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 78 U.K.: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 79 U.K.: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 80 U.K.: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 81 U.K.: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 82 U.K.: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 83 Italy: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 84 Italy: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 85 Italy: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 86 Italy: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 87 Italy: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 88 Italy: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 89 Spain: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 90 Spain: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 91 Spain: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 92 Spain: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 93 Spain: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 94 Spain: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 95 Rest of Europe: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 96 Rest of Europe: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 97 Rest of Europe: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 98 Rest of Europe: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 99 Rest of Europe: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 100 Rest of Europe: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 101 Asia-Pacific: IVD Quality Control Market, by Country/Region, 2021–2030 (USD Million)
Table 102 Asia-Pacific: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 103 Asia-Pacific: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 104 Asia-Pacific: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 105 Asia-Pacific: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 106 Asia-Pacific: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 107 Asia-Pacific: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 108 China: Mass Testing Drives to Control The Spread of Covid-19 Infections
Table 109 China: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 110 China: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 111 China: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 112 China: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 113 China: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 114 China: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 115 Japan: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 116 Japan: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 117 Japan: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 118 Japan: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 119 Japan: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 120 Japan: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 121 India: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 122 India: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 123 India: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 124 India: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 125 India: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 126 India: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 127 Rest of Asia-Pacific: Estimated Number of New Cancer Cases, by Country (2020–2030)
Table 128 Rest of Asia-Pacific: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 129 Rest of Asia-Pacific: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 130 Rest of Asia-Pacific: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 131 Rest of Asia-Pacific: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 132 Rest of Asia-Pacific: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 133 Rest of Asia-Pacific: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 134 Latin America: IVD Quality Control Market, by Country/Region, 2021–2030 (USD Million)
Table 135 Latin America: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 136 Latin America: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 137 Latin America: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 138 Latin America: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 139 Latin America: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 140 Latin America: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 141 Brazil: Testing Initiatives for COVID-19
Table 142 Brazil: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 143 Brazil: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 144 Brazil: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 145 Brazil: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 146 Brazil: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 147 Brazil: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 148 Mexico: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 149 Mexico: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 150 Mexico: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 151 Mexico: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 152 Mexico: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 153 Mexico: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 154 Rest of Latin America: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 155 Rest of Latin America: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 156 Rest of Latin America: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 157 Rest of Latin America: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 158 Rest of Latin America: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 159 Rest of Latin America: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 160 Middle East & Africa: IVD Quality Control Market, by Offering, 2021–2030 (USD Million)
Table 161 Middle East & Africa: Quality Control Products Market, by Type, 2021–2030 (USD Million)
Table 162 Middle East & Africa: Quality Control Products Market, by Function, 2021–2030 (USD Million)
Table 163 Middle East & Africa: IVD Quality Control Market, by Technology, 2021–2030 (USD Million)
Table 164 Middle East & Africa: IVD Quality Control Market, by Application, 2021–2030 (USD Million)
Table 165 Middle East & Africa: IVD Quality Control Market, by End User, 2021–2030 (USD Million)
Table 166 Recent Developments, by Company, 2020–2023
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for this Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global IVD Quality Control Market, by Offering, 2023 Vs. 2030 (USD Million)
Figure 8 Global IVD Quality Control Market, by Technology, 2023 Vs. 2030 (USD Million)
Figure 9 Global IVD Quality Control Market, by Application, 2023 Vs. 2030 (USD Million)
Figure 10 Global IVD Quality Control Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 11 Global IVD Quality Control Market, by Geography
Figure 12 Healthcare Expenditure as a Percentage of GDP in Major Countries, 2015 Vs. 2020
Figure 13 Estimated Number of People Living With HIV, by Region, 2015 Vs. 2021 (In Thousand)
Figure 14 Global Diabetes Prevalence in People Aged 20–79 Years, by Region, 2021 Vs. 2030 Vs. 2045 (In Million)
Figure 15 USFDA Regulatory Pathways for IVD Products
Figure 16 EU Regulatory Pathway - IVDR 2017/746
Figure 17 China: Medical Device Classification and Pre-Market Requirements for IVD Devices
Figure 18 Porter's Five Forces Analysis
Figure 19 Global In Vitro Diagnostics (IVD) Market, by Offering, 2023 (USD Million)
Figure 20 Global IVD Quality Control Market, by Offering, 2023 Vs. 2030 (USD Million)
Figure 21 Global IVD Quality Control Market, by Technology, 2023 Vs. 2030 (USD Million)
Figure 22 Global IVD Quality Control Market, by Application, 2023 Vs. 2030 (USD Million)
Figure 23 Global IVD Quality Control Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 24 Global IVD Quality Control Market Assessment, by Country/Region, 2023–2030 (USD Million)
Figure 25 North America: IVD Quality Control Market Snapshot
Figure 26 Europe: IVD Quality Control Market Snapshot
Figure 27 Health Expenditure (2015–2020)
Figure 28 Asia-Pacific: IVD Quality Control Market Snapshot
Figure 29 China: Independent Medical Laboratories Market, 2015–2019 (USD Million)
Figure 30 Latin America: IVD Quality Control Market Snapshot
Figure 31 Key Growth Strategies Adopted by Leading Players, 2020–2023
Figure 32 IVD Quality Control Market: Competitive Benchmarking, by Offering
Figure 33 IVD Quality Control Market: Competitive Benchmarking, by Geography
Figure 34 Competitive Dashboard: IVD Quality Control Market
Figure 35 Siemens Healthineers AG: Financial Overview (2022)
Figure 36 Bio-Rad Laboratories, Inc.: Financial Overview (2022)
Figure 37 Danaher Corporation: Financial Overview (2022)
Figure 38 LGC GROUP: Financial Overview (2021)
Figure 39 Thermo Fisher Scientific Inc.: Financial Overview (2022)
Figure 40 QuidelOrtho Corporation: Financial Overview (2022)
Figure 41 Bio-Techne Corporation: Financial Overview (2022)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings